32 related articles for article (PubMed ID: 32920586)
1. Cardiovascular Health in the COVID-19 Era: A Call for Action and Education.
Vallabhajosyula S; Friedman PA; Bell MR
Mayo Clin Proc; 2020 Aug; 95(8):1584-1588. PubMed ID: 32753133
[No Abstract] [Full Text] [Related]
2. COVID-19 and Calcineurin Inhibitors: Should They Get Left Out in the Storm?
Willicombe M; Thomas D; McAdoo S
J Am Soc Nephrol; 2020 Jun; 31(6):1145-1146. PubMed ID: 32312797
[No Abstract] [Full Text] [Related]
3. No double-edged sword and no doubt about the relation between smoking and COVID-19 severity.
Gallus S; Lugo A; Gorini G
Eur J Intern Med; 2020 Jul; 77():33-35. PubMed ID: 32564904
[No Abstract] [Full Text] [Related]
4. Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19.
Potter H; Boyd TD; Clarke P; Pelak VS; Tyler KL
F1000Res; 2020; 9():345. PubMed ID: 32704352
[TBL] [Abstract][Full Text] [Related]
5. Review on lipegfilgrastim.
Gasparic M; Leyman S
Int J Nanomedicine; 2015; 10():6863-4. PubMed ID: 26604752
[No Abstract] [Full Text] [Related]
6. Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19.
Taha M; Sharma A; Soubani A
Respir Med Case Rep; 2020; 31():101231. PubMed ID: 32999856
[TBL] [Abstract][Full Text] [Related]
7. Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF?
Lazarus HM; Gale RP
Acta Haematol; 2021; 144(3):350-351. PubMed ID: 33161397
[No Abstract] [Full Text] [Related]
8. Can immunological manipulation defeat SARS-CoV-2? Why G-CSF induced neutrophil expansion is worth a clinical trial: G-CSF treatment against COVID-19.
Katayama H
Bioessays; 2021 Feb; 43(2):e2000232. PubMed ID: 33166093
[TBL] [Abstract][Full Text] [Related]
9. Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper.
Cooksley T; Font C; Scotte F; Escalante C; Johnson L; Anderson R; Rapoport B
Support Care Cancer; 2021 Feb; 29(2):1129-1138. PubMed ID: 33230644
[TBL] [Abstract][Full Text] [Related]
10. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study.
Temesgen Z; Assi M; Shweta FNU; Vergidis P; Rizza SA; Bauer PR; Pickering BW; Razonable RR; Libertin CR; Burger CD; Orenstein R; Vargas HE; Palraj R; Dababneh AS; Chappell G; Chappell D; Ahmed O; Sakemura R; Durrant C; Kenderian SS; Badley AD
Mayo Clin Proc; 2020 Nov; 95(11):2382-2394. PubMed ID: 33153629
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory phenotyping predicts clinical outcome in COVID-19.
Burke H; Freeman A; Cellura DC; Stuart BL; Brendish NJ; Poole S; Borca F; Phan HTT; Sheard N; Williams S; Spalluto CM; Staples KJ; Clark TW; Wilkinson TMA;
Respir Res; 2020 Sep; 21(1):245. PubMed ID: 32962703
[TBL] [Abstract][Full Text] [Related]
12. Time to revisit the use of G-CSF after allogeneic haematopoietic cell transplantation in COVID-19 era?
Malek AE
Br J Cancer; 2021 Mar; 124(7):1183. PubMed ID: 33398065
[TBL] [Abstract][Full Text] [Related]
13. The good, the bad and the ugly: G-CSF, ageing and neutrophils-Implications for severe COVID-19.
Moss DL; Rappaport J
J Leukoc Biol; 2021 Jun; 109(6):1017-1018. PubMed ID: 33866607
[TBL] [Abstract][Full Text] [Related]
14. A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis.
Sereno M; Jimenez-Gordo AM; Baena-Espinar J; Aguado C; Mielgo X; Pertejo A; Álvarez-Álvarez R; Sánchez A; López JL; Molina R; López-Alfonso A; Hernández B; Chiara LE; Martín AM; López-Martín A; Dorta M; Collazo-Lorduy A; Casado E; de Molina AR; Colmenarejo G
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439359
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factors (G-CSF) and Covid-19: a double-edged sword?
Tralongo AC; Danova M
Infez Med; 2020 Sep; 28(3):459-460. PubMed ID: 32920586
[TBL] [Abstract][Full Text] [Related]
16. How to face cancer treatment in the COVID-19 era.
Brandes AA; Di Nunno V
Expert Rev Anticancer Ther; 2020 Jun; 20(6):429-432. PubMed ID: 32370563
[No Abstract] [Full Text] [Related]
17. Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era.
Alkan A; Uncu A; Taşkıran I; Tanrıverdi Ö
Clinics (Sao Paulo); 2020; 75():e2033. PubMed ID: 32638908
[No Abstract] [Full Text] [Related]
18. Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19.
Gatto L; Franceschi E; Nunno VD; Brandes AA
Immunotherapy; 2020 Oct; 12(15):1111-1114. PubMed ID: 32594820
[No Abstract] [Full Text] [Related]
19. Guiding principles for cardiology care in times of the COVID-19 Pandemic: Gazing through the crystal ball.
Sahu A; Kapoor A
Ann Card Anaesth; 2020; 23(4):532-536. PubMed ID: 33109822
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
